FDA Investigator Ann Marie Schofield

Ann Marie Schofield has inspections in 6 countries as of 01 Aug 2023. Ann Marie Schofield has collaborated with a combinined 4112 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
01 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America, Ireland, France, Belgium, Denmark
Co-Investigator(s):
A Williams, Adetutu M Gidado, Alicia Gilbert, Alicia M Mozzachio, Alla Kachko, PhD, Amy M Cramer, Ana S Cabrera, Anastasia I Offordile, Andrew Chang, Andria L Kuhlman, Angela Jourdain, Angela R Jourdain, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Annemarie Bodnar, Audrey Thereset Uy, Barbara Janine Breithaupt, Barry Cherney, PhD, Brentley S Collins, Brian D Nicholson, Brian S Keefer, Bruce D Meade, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Carl Lee, Carla J Lundi, Carol L Rehkopf, Carolyn Yong, PhD, Carrie Ann Plucinski, Caryn M Mcnab, CDR Donald Ertel, CDR Jeremy L Wally, PhD, Chao Ming Tsai, Chiang Syin, PhD, Christian D Lynch (CDL), Christina A Miller, Christina J Sauder, PhD, Christina V Santos, Christine A Harman, PhD, Christopher J Adams, Christopher R Czajka, Claire M Minden, Craig D Zagata, Creighton T Tuzon, Cynthia Jim, CSO, Cynthia L Kelley, Daniel J Grabicki, Daniel Lagasse, Dave Hafner, David E Bailey, David J Hafner, David K Lau, David M Beltran, David Perkins, Dawn L Wydner, Deborah M Trout, Debra I Love, Debra J Bennett, Debra L Pagano, Dongping Dai, PhD, Dr. Barbara D Paul, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Eileen A Liu, Ellen Huang, Elmina E Akwo, Freddy Ortiz Colon, Gene D Arcy, Gerald B Seaborn, Jr, Ginger M Sykes, Hala L Selby, Haruhiko Murata, Helen B Ricalde, Holly Brevig, Humera Khan, J David Doleski, Jacqueline Mdiaz Albertini, James C Lee, PharmD, James L Dunnie, Jr, James M Mason, James P Mcevoy, Jason F Chancey, Jean Lhu Primmer, Jean M Kelahan, Jeanne M Morris, Jeffrey M Watson, Jennifer L Bridgewater, Jennifer Macmillan, Joan A Loreng, Joan Adamo, Joan Johnson, Joanne E King, Joanne M Hajoway, Joanne Pryzbylik, John S Hartford, John Stansberry, PhD, Jonee J Mearns, Jose Acruz Gonzalez, Joseph George, Joy Rkozlowski Klena, Julianne C Mccullough, Julie D Bringger, Junho Pak, Karen E D'orazio, Karyn M Campbell, Katherine E Jacobitz, Kathleen B Mihalik, Kathryn Carbone, MD, Kelly I Anderson, Kelly N Kerr, Kenneth M Gordon, Kevin P Foley, Kimberly M Bigler, Kristen D Evans, Laurel A Beer, Laurie B Frazier, LCDR Debra Emerson, LCDR Margaret E Digennaro, Lequita M Mayhew, Linda Thai, Lisa Feela, Lisa M Bellows, Lisa M Feola, Lisa P Oakes, Lisa Pierce Oakes, Lorelei S Jarrell, LT John M Mastalski, Lydia Irosas Marty, Marian E Major, PhD, Marie Bbuen Bigornia, Marion Michaelis, Mariza M Jafary, Marla A Cassidy, Marsha W Major, Martha T Olone, Mary T Carden, Meihong Liu, Michael Curbag, Michael Gurbarg, Michele L Forster, PhD, Michele Perry Williams, Mihaly S Ligmond, Mike M Rashti, Mizanne E Lewis, Morris Sheldon, PhD, Myra K Casey, Nancy E Kirschbaum, Nancy L Neiger, Nancy T Waites, Nicholas A Violand, Nicholas F Lyons, Nicholas P Diorio, Nicole J Clausen, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paula A Trost, Phillip M Pontikos, Phung Thien Nguyen, Prabhu P Raju, Qiao Y Bobo, Ralph A Erickson, Ramjay Vatsan, PhD, Ramon E Martinez, Randa Melhem, PhD, Rebecca K Olin, Regina T Brown, Richard D Manney, Richard H Penta, Richard W Thornton, Robert B Shibuya, MD, Robert C Coleman, Robert D Tollefsen, Robert W Jennings, Rochelle K Kimmel, Roman Drews, PhD, Roman T Drews, PhD, Rona Leblanc, PhD, Rose Ashley, Rose M Ashley, Russ R Rivy, Russell K Riley, Samantha J Bradley, Sarah Forney, Scott E Norris, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Sheldon Morris, Sherry G Bous, Sheryl A Kochman, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Stephanie A Slater, MS, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Gonzales, Steven A Rubin, Steven C Derrick, Steven E Bowen, PhD, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Tammy L Chavis, Teresita C Mercado, Terrig Thomas, PhD, Thomas J Arista, Thunder N Dunkijacobs, Tina S Roecklein, Todd M Stankewicz, Vijaya L Simhadri, Vlada Matusovsky, Wei Wang, PhD, William D Tingley, Xiao Wang, Xiaokuang Lai, PhD, Yonggang Wang, PhD, Yumi J Hiramine, Zachary L Miller, Zhong Li, PhD, Zuben E Sauna, PhD

Ann Marie Schofield's Documents

Publish Date Document Type Title
December, 2000 FDA 483 Bayer HealthCare LLC - Form 483, 2000-12-07
May, 2002 EIR Merck Sharp & Dohme LLC - EIR, 2002-05-03
May, 2001 FDA 483 Aquitaine Pharm International - Form 483, 2001-05-11
March, 2001 FDA 483 Genzyme Biosurgery - Form 483, 2001-03-29
March, 2000 FDA 483 Allergan Botox, Ltd. - Form 483, 2000-03-09
October, 2000 EIR Merck Sharp & Dohme LLC - EIR, 2000-10-11
May, 2001 EIR Fareva Pau - EIR, 2001-06-06
August, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-08-15
May, 2002 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2002-05-20
February, 2000 EIR MSD International GmbH - EIR, 2000-07-26
October, 2001 EIR Antigen Laboratories-Columbus - EIR, 2001-10-12
August, 2001 FDA 483 Ortho Biotech Products LP - Form 483, 2001-08-31
May, 2001 EIR Baxalta Belgium Manufacturing SA - EIR, 2001-05-02
August, 2002 FDA 483 Response AbbVie Inc. - Form 483R, 2002-08-28
July, 2001 FDA 483 Ortho-Clinical Diagnostics, Inc. - Form 483, 2001-07-27
March, 2002 FDA 483 Novo Nordisk A/S - Hax - Form 483, 2002-03-07
March, 2001 EIR Vericel Corporation - EIR, 2001-03-29
June, 2001 FDA 483 AIM ImmunoTech Inc - Form 483, 2001-06-28
May, 2001 FDA 483 Response Baxalta Belgium Manufacturing SA - Form 483R, 2001-05-11
October, 2000 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2000-10-11
August, 2000 FDA 483 Response DPT Lakewood, Inc. - Form 483R, 2000-09-01
October, 2001 FDA 483 Antigen Laboratories-Columbus - Form 483, 2001-10-12
October, 2002 EIR Johnson & Johnson Pharmaceutical Research & Development, LLC - EIR, 2002-10-28
September, 2002 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2002-09-13
May, 2002 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2002-05-03
August, 2002 EIR AbbVie Inc. - EIR, 2002-08-15
September, 2002 FDA 483 Response Emergent Biodefense Operations Lansing LLC - Form 483R, 2002-10-07
August, 2000 FDA 483 DPT Lakewood, Inc. - Form 483, 2000-08-11
June, 2002 FDA 483 Merck Teknika LLC - Form 483, 2002-06-07
August, 2001 EIR Ortho Clinical Diagnostics - EIR, 2001-08-31
December, 2000 EIR Bayer HealthCare LLC - EIR, 2000-12-07
May, 2001 FDA 483 Baxter Healthcare Corporation, Hyland Division - Form 483, 2001-05-02
July, 2001 EIR Ortho-Clinical Diagnostics, Inc. - EIR, 2001-07-27
February, 2000 FDA 483 MSD International GmbH - Form 483, 2000-02-29
June, 2002 EIR Merck Teknika LLC - EIR, 2002-06-07
October, 2002 FDA 483 Response Johnson & Johnson Pharmaceutical Research & Development, LLC - Form 483R, 2002-11-11
October, 2002 FDA 483 Johnson & Johnson Pharmaceutical Research & Development, LLC - Form 483, 2002-10-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more